Sanjeev Tummala, MD
Gastroenterology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tummala’s office at (650) 254-5200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C53683 · Current
Licensed to practise in California · since 2009 · expires 2026-11-30 · Osmania University, Gandhi Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$85,339
Medicare paid this office $85,339 for 387 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 119 | $28,851 | $240 |
| Biopsy of large bowel using a flexible endoscope | 136 | $10,284 | $76 |
| Short return visit (20+ min) | 93 | $9,524 | $80 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 90 | $7,820 | $87 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $4,852 | $202 |
See all 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 119 | $28,851 | $240 |
| Biopsy of large bowel using a flexible endoscope | 136 | $10,284 | $76 |
| Short return visit (20+ min) | 93 | $9,524 | $80 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 90 | $7,820 | $87 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $4,852 | $202 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,363 | $153 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,100 | $207 |
| Return visit (30+ min) | 25 | $2,853 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,651 | $115 |
| New patient visit (30+ min) | 19 | $1,828 | $96 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,800 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,483 | $67 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,332 | $102 |
| Short return visit | 13 | $732 | $56 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 134 | $569 | $4 |
| Measurement of liver stiffness | 13 | $322 | $25 |
Procedures Medicare counted
| Colonoscopy | 59 | More than 67% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 83 | More than 73% of doctors who do this |
Who their Medicare patients are
387 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 11% · Women 47% · Also on Medicaid 12% · Health risk score 1.11. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 68% · Diabetes 25% · Chronic kidney disease 24% · Coronary heart disease 21% · Atrial fibrillation 19% · Cancer 18% · Depression 18% · Heart failure 11% · COPD 7% · Stroke 7% · Dementia 6%.
The office billed $894,058, Medicare allowed $105,288 and paid $85,339; for 840 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 387 | 840 | 75 | 1.11 | $894,058 | $85,339 |
| 2023 | 389 | 866 | 75 | 1.23 | $825,767 | $90,788 |
| 2022 | 359 | 773 | 75 | 1.24 | $649,577 | $80,492 |
| 2021 | 364 | 901 | 74 | 0.95 | $772,693 | $91,712 |
| 2020 | 346 | 794 | 74 | 1.12 | $663,692 | $76,447 |
| 2019 | 379 | 953 | 74 | 1.07 | $807,047 | $90,721 |
| 2018 | 331 | 807 | 74 | 1.00 | $613,690 | $70,800 |
| 2017 | 366 | 826 | 73 | 1.11 | $571,570 | $72,853 |
| 2016 | 346 | 632 | 72 | 1.06 | $543,753 | $72,875 |
| 2015 | 343 | 634 | 72 | 1.14 | $517,163 | $82,787 |
| 2014 | 303 | 595 | 73 | 1.05 | $498,336 | $74,665 |
| 2013 | 282 | 517 | 72 | 1.23 | $452,544 | $67,399 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 107 | $26,251 | $245 |
| Return visit (30+ min) | 99 | $13,592 | $112 |
| Biopsy of large bowel using a flexible endoscope | 119 | $12,013 | $101 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 101 | $8,383 | $81 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 23 | $4,854 | $211 |
| Short return visit (20+ min) | 51 | $4,449 | $79 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 19 | $4,008 | $211 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 39 | $2,970 | $74 |
| New patient visit (30+ min) | 29 | $2,863 | $99 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,867 | $170 |
| New patient visit (45+ min) | 12 | $1,769 | $147 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 143 | $681 | $5 |
2022: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $17,597 | $235 |
| Return visit (30+ min) | 95 | $14,276 | $113 |
| Biopsy of large bowel using a flexible endoscope | 67 | $7,424 | $111 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 81 | $6,485 | $79 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | $5,420 | $208 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,300 | $172 |
| Short return visit (20+ min) | 50 | $3,934 | $77 |
| New patient visit (30+ min) | 38 | $3,279 | $86 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,190 | $213 |
| New patient visit (45+ min) | 15 | $2,097 | $140 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,353 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,108 | $65 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 126 | $640 | $5 |
2021: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 95 | $22,393 | $236 |
| Return visit (30+ min) | 91 | $14,095 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 105 | $9,868 | $94 |
| Biopsy of large bowel using a flexible endoscope | 102 | $8,618 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,098 | $179 |
| New patient visit (45+ min) | 31 | $4,810 | $155 |
| Short return visit (20+ min) | 56 | $4,776 | $75 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,438 | $211 |
| New patient visit (30+ min) | 27 | $2,776 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,993 | $66 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 172 | $864 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $164 | $15 |
2020: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $20,132 | $240 |
| Return visit (30+ min) | 79 | $9,024 | $94 |
| Biopsy of large bowel using a flexible endoscope | 93 | $8,704 | $93 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 80 | $7,675 | $95 |
| Short return visit (20+ min) | 71 | $4,849 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,149 | $189 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 20 | $4,065 | $203 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,637 | $220 |
| New patient visit (45+ min) | 20 | $2,370 | $119 |
| New patient visit (30+ min) | 24 | $2,293 | $96 |
| Long return visit (40+ min) | 17 | $1,778 | $105 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,422 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,354 | $97 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,108 | $74 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 143 | $767 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $212 | $15 |
2019: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 87 | $20,513 | $236 |
| Biopsy of large bowel using a flexible endoscope | 116 | $12,308 | $106 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $9,170 | $86 |
| Short return visit (20+ min) | 97 | $8,422 | $66 |
| Return visit (30+ min) | 71 | $8,395 | $99 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $6,038 | $216 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,160 | $184 |
| New patient visit (45+ min) | 21 | $3,121 | $149 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $3,021 | $216 |
| Long return visit (40+ min) | 17 | $2,362 | $139 |
| New patient visit (30+ min) | 23 | $2,001 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,259 | $60 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 186 | $951 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 20 | $306 | $15 |
2018: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 67 | $15,695 | $234 |
| Return visit (30+ min) | 94 | $11,276 | $89 |
| Biopsy of large bowel using a flexible endoscope | 93 | $8,726 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | $6,122 | $94 |
| New patient visit (45+ min) | 37 | $4,994 | $135 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 20 | $4,145 | $207 |
| Short return visit (20+ min) | 53 | $3,914 | $63 |
| Long return visit (40+ min) | 25 | $3,020 | $121 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,765 | $213 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,574 | $112 |
| New patient visit (30+ min) | 16 | $1,258 | $79 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 15 | $841 | $56 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 143 | $711 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 35 | $443 | $11 |
| Injection beneath lining of large bowel using a flexible endoscope | 19 | $292 | $15 |
2017: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | $13,793 | $234 |
| Return visit (30+ min) | 87 | $11,251 | $94 |
| Biopsy of large bowel using a flexible endoscope | 84 | $8,828 | $104 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,940 | $212 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $5,493 | $93 |
| New patient visit (45+ min) | 34 | $4,754 | $140 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,248 | $212 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 54 | $3,778 | $70 |
| Long return visit (40+ min) | 22 | $2,978 | $135 |
| Short return visit (20+ min) | 44 | $2,768 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,709 | $114 |
| New patient visit (30+ min) | 18 | $1,639 | $91 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 57 | $677 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 140 | $593 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $353 | $29 |
2016: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $12,161 | $238 |
| Return visit (30+ min) | 88 | $11,327 | $91 |
| Biopsy of large bowel using a flexible endoscope | 85 | $10,221 | $120 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $6,465 | $96 |
| New patient visit (45+ min) | 39 | $5,710 | $146 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | $5,544 | $213 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,350 | $218 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 55 | $4,222 | $75 |
| Short return visit (20+ min) | 47 | $3,279 | $63 |
| Long return visit (40+ min) | 15 | $1,824 | $122 |
| New patient visit (30+ min) | 20 | $1,559 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,458 | $121 |
| Injection beneath lining of large bowel using a flexible endoscope | 16 | $423 | $26 |
2015: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 55 | $15,672 | $285 |
| Return visit (30+ min) | 83 | $12,205 | $101 |
| Biopsy of large bowel using a flexible endoscope | 79 | $11,394 | $142 |
| New patient visit (45+ min) | 43 | $6,771 | $157 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $6,057 | $242 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $5,190 | $236 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $4,904 | $96 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 44 | $3,620 | $82 |
| Short return visit (20+ min) | 40 | $3,284 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,292 | $127 |
| New patient visit (30+ min) | 22 | $2,189 | $99 |
| Long return visit (40+ min) | 14 | $1,866 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,396 | $66 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $351 | $27 |
2014: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 65 | $17,419 | $268 |
| Return visit (30+ min) | 100 | $14,256 | $93 |
| Biopsy of large bowel using a flexible endoscope | 78 | $9,990 | $128 |
| New patient visit (45+ min) | 45 | $6,506 | $145 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $6,021 | $241 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | $3,947 | $74 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,890 | $241 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 29 | $2,394 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,574 | $56 |
| Short return visit (20+ min) | 16 | $1,226 | $68 |
| Diagnostic exam of anus using an endoscope | 11 | $971 | $88 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $289 | $26 |
2013: 10 services
| Return visit (30+ min) | 93 | $12,715 | $93 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $12,575 | $262 |
| Biopsy of large bowel using a flexible endoscope | 63 | $9,449 | $150 |
| New patient visit (45+ min) | 58 | $7,860 | $136 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $5,090 | $242 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $5,075 | $101 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 16 | $1,542 | $91 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,486 | $87 |
| Diagnostic exam of anus using an endoscope | 11 | $1,113 | $93 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $483 | $44 |
Drugs they prescribed that Part D paid
$269,356
Pharmacies billed $269,356 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 855) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
610 generic and 245 brand-name prescriptions · $269,356 in drug cost · 29 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 88 | $67,964 | $772 |
| Xifaxan | 17 | $51,641 | $3,038 |
| Vemlidy | 19 | $35,754 | $1,882 |
| Trulance | 11 | $10,306 | $937 |
| Dexlansoprazole Dr | 24 | $8,264 | $344 |
See all 17 drugs
| Linzess | 88 | $67,964 | $772 |
| Xifaxan | 17 | $51,641 | $3,038 |
| Vemlidy | 19 | $35,754 | $1,882 |
| Trulance | 11 | $10,306 | $937 |
| Dexlansoprazole Dr | 24 | $8,264 | $344 |
| Mesalamine | 29 | $7,732 | $267 |
| Sod Sulf-Potass Sulf-Mag Sulf | 84 | $5,611 | $67 |
| Pantoprazole | 194 | $2,565 | $13 |
| Peg 3350-Electrolyte | 91 | $1,928 | $21 |
| Ursodiol | 14 | $1,880 | $134 |
| Entecavir | 14 | $922 | $66 |
| Omeprazole | 50 | $854 | $17 |
| Gavilyte-G | 50 | $694 | $14 |
| Gavilyte-C | 19 | $299 | $16 |
| Peg-3350 and Electrolytes | 18 | $271 | $15 |
| Famotidine | 27 | $160 | $6 |
| Dicyclomine | 12 | $78 | $6 |
Year by year
| 2024 | 855 | 391 | 0% (0) | 29% | $269,356 |
| 2023 | 754 | 344 | 0% (0) | 31% | $168,113 |
| 2022 | 717 | 279 | 0% (0) | 42% | $366,994 |
| 2021 | 765 | 305 | None | 42% | $219,384 |
| 2020 | 654 | 244 | 0% (0) | 36% | $235,595 |
| 2019 | 715 | 266 | 0% (0) | 35% | $238,806 |
| 2018 | 623 | 227 | 0% (0) | 41% | $374,146 |
| 2017 | 516 | 211 | 0% (0) | 47% | $401,612 |
| 2016 | 523 | 196 | None | None | $249,985 |
| 2015 | 467 | 176 | None | 38% | $839,594 |
| 2014 | 357 | 117 | 0% (0) | 40% | $573,234 |
| 2013 | 295 | 78 | 0% (0) | 32% | $51,164 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Linzess | 74 | $50,861 | $687 |
| Vemlidy | 18 | $28,055 | $1,559 |
| Dexlansoprazole Dr | 24 | $10,559 | $440 |
| Sod Sulf-Potass Sulf-Mag Sulf | 95 | $7,467 | $79 |
| Mesalamine | 11 | $5,078 | $462 |
| Peg 3350-Electrolyte | 122 | $2,745 | $22 |
| Pantoprazole | 148 | $2,734 | $18 |
| Lactulose | 15 | $857 | $57 |
| Omeprazole | 56 | $828 | $15 |
| Dicyclomine | 19 | $777 | $41 |
| Sucralfate | 22 | $592 | $27 |
| Famotidine | 19 | $136 | $7 |
2022: 15 drugs
| Vemlidy | 46 | $64,058 | $1,393 |
| Xifaxan | 17 | $46,533 | $2,737 |
| Linzess | 66 | $42,751 | $648 |
| Dexilant | 20 | $9,692 | $485 |
| Suprep | 77 | $8,782 | $114 |
| Mesalamine | 12 | $7,372 | $614 |
| Pantoprazole | 163 | $2,841 | $17 |
| Peg 3350-Electrolyte | 73 | $1,341 | $18 |
| Sod Sulf-Potass Sulf-Mag Sulf | 13 | $981 | $75 |
| Omeprazole | 52 | $645 | $12 |
| Azathioprine | 11 | $615 | $56 |
| Entecavir | 16 | $488 | $31 |
| Dicyclomine | 13 | $362 | $28 |
| Peg-3350 and Electrolytes | 11 | $151 | $14 |
| Famotidine | 19 | $140 | $7 |
2021: 14 drugs
| Vemlidy | 60 | $77,819 | $1,297 |
| Linzess | 57 | $31,173 | $547 |
| Xifaxan | 11 | $22,448 | $2,041 |
| Dexilant | 24 | $15,786 | $658 |
| Suprep | 118 | $12,996 | $110 |
| Mesalamine | 15 | $8,978 | $599 |
| Pantoprazole | 177 | $3,385 | $19 |
| Omeprazole | 71 | $1,093 | $15 |
| Peg 3350-Electrolyte | 24 | $423 | $18 |
| Azathioprine | 17 | $413 | $24 |
| Entecavir | 12 | $354 | $29 |
| Dicyclomine | 20 | $310 | $16 |
| Famotidine | 25 | $293 | $12 |
| Gavilyte-G | 11 | $120 | $11 |
2020: 13 drugs
| Vemlidy | 54 | $74,904 | $1,387 |
| Xifaxan | 19 | $40,208 | $2,116 |
| Linzess | 44 | $24,114 | $548 |
| Mesalamine | 11 | $10,244 | $931 |
| Dexilant | 13 | $7,842 | $603 |
| Suprep | 63 | $6,643 | $105 |
| Pantoprazole | 151 | $2,517 | $17 |
| Omeprazole | 81 | $1,225 | $15 |
| Entecavir | 16 | $906 | $57 |
| Famotidine | 20 | $305 | $15 |
| Peg 3350-Electrolyte | 19 | $261 | $14 |
| Gavilyte-C | 18 | $241 | $13 |
| Dicyclomine | 16 | $163 | $10 |
2019: 17 drugs
| Vemlidy | 51 | $57,793 | $1,133 |
| Xifaxan | 15 | $33,320 | $2,221 |
| Linzess | 53 | $27,805 | $525 |
| Mesalamine | 12 | $8,211 | $684 |
| Dexilant | 13 | $7,447 | $573 |
| Suprep | 72 | $7,235 | $100 |
| Pantoprazole | 123 | $1,737 | $14 |
| Entecavir | 21 | $1,217 | $58 |
| Omeprazole | 74 | $1,075 | $15 |
| Ranitidine | 74 | $682 | $9 |
| Famotidine | 12 | $250 | $21 |
| Lactulose | 13 | $250 | $19 |
| Peg 3350-Electrolyte | 12 | $227 | $19 |
| Gavilyte-C | 20 | $221 | $11 |
| Gavilyte-N | 11 | $188 | $17 |
| Dicyclomine | 21 | $188 | $9 |
| Peg 3350-Electrolyte | 16 | $127 | $8 |
2018: 13 drugs
| Vemlidy | 46 | $48,918 | $1,063 |
| Xifaxan | 19 | $36,988 | $1,947 |
| Linzess | 48 | $23,960 | $499 |
| Mesalamine | 13 | $8,928 | $687 |
| Suprep | 84 | $7,873 | $94 |
| Dexilant | 13 | $7,127 | $548 |
| Omeprazole | 79 | $956 | $12 |
| Pantoprazole | 86 | $903 | $10 |
| Entecavir | 15 | $634 | $42 |
| Peg 3350-Electrolyte | 31 | $501 | $16 |
| Ranitidine | 44 | $417 | $9 |
| Gavilyte-N | 13 | $212 | $16 |
| Dicyclomine | 24 | $95 | $4 |
2017: 12 drugs
| Linzess | 48 | $23,232 | $484 |
| Viread | 20 | $21,177 | $1,059 |
| Vemlidy | 19 | $19,220 | $1,012 |
| Suprep | 64 | $5,674 | $89 |
| Dexilant | 15 | $5,151 | $343 |
| Entecavir | 11 | $3,065 | $279 |
| Pantoprazole | 62 | $801 | $13 |
| Peg 3350-Electrolyte | 40 | $570 | $14 |
| Omeprazole | 64 | $541 | $8 |
| Gavilyte-N | 15 | $265 | $18 |
| Ranitidine | 21 | $150 | $7 |
| Dicyclomine | 40 | $128 | $3 |
2016: 13 drugs
| Viread | 28 | $38,961 | $1,391 |
| Xifaxan | 15 | $24,440 | $1,629 |
| Lialda | 11 | $13,884 | $1,262 |
| Linzess | 31 | $11,894 | $384 |
| Dexilant | 37 | $9,845 | $266 |
| Peg 3350-Electrolyte | 61 | $995 | $16 |
| Omeprazole | 72 | $664 | $9 |
| Pantoprazole | 45 | $642 | $14 |
| Gavilyte-N | 26 | $462 | $18 |
| Spironolactone | 14 | $279 | $20 |
| Ranitidine | 17 | $140 | $8 |
| Dicyclomine | 27 | $85 | $3 |
| Furosemide | 14 | $66 | $5 |
2015: 13 drugs
| Harvoni | 21 | $675,270 | $32,156 |
| Xifaxan | 14 | $22,793 | $1,628 |
| Viread | 20 | $18,752 | $938 |
| Dexilant | 17 | $4,184 | $246 |
| Moviprep | 22 | $1,782 | $81 |
| Nadolol | 13 | $1,144 | $88 |
| Peg 3350-Electrolyte | 41 | $710 | $17 |
| Omeprazole | 65 | $646 | $10 |
| Spironolactone | 32 | $505 | $16 |
| Gavilyte-N | 24 | $436 | $18 |
| Pantoprazole | 37 | $397 | $11 |
| Furosemide | 23 | $103 | $4 |
| Dicyclomine | 19 | $43 | $2 |
2014: 10 drugs
| Xifaxan | 15 | $24,362 | $1,624 |
| Viread | 17 | $23,468 | $1,380 |
| Dexilant | 15 | $2,781 | $185 |
| Moviprep | 19 | $1,495 | $79 |
| Spironolactone | 22 | $801 | $36 |
| Pantoprazole | 33 | $657 | $20 |
| Omeprazole | 63 | $596 | $9 |
| Peg-3350 | 25 | $433 | $17 |
| Polyethylene Glycol 3350 | 11 | $172 | $16 |
| Furosemide | 18 | $84 | $5 |
2013: 7 drugs
| Viread | 17 | $23,959 | $1,409 |
| Moviprep | 24 | $1,717 | $72 |
| Omeprazole | 89 | $1,169 | $13 |
| Pantoprazole | 21 | $646 | $31 |
| Spironolactone | 15 | $435 | $29 |
| Furosemide | 17 | $120 | $7 |
| Propranolol | 15 | $68 | $5 |
Money from drug and device companies
$89 in 2025
| 2025 | 2 | 2 | None | $89 |
| 2024 | 1 | 1 | None | $12 |
| 2023 | 1 | 4 | None | $212 |
| 2022 | 1 | 1 | None | $92 |
| 2019 | 1 | 6 | None | $129 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | None | $76 | 1 payment
|
| Conmed | Conmed Biliary | $14 | 1 payment
|
See all 2 published payments
| Conmed | Meals · 2025-10-04 | Conmed Biliary | $14 |
| Gilead Sciences | Meals · 2025-05-01 | None | $76 |
See earlier years (2024, 2023, 2022, 2019)
2024: $12
| Micro-tech Endoscopy USA | Eyemx | $12 | 1 payment
|
2023: $212
| Gilead Sciences | Vemlidy | $212 | 4 payments
|
2022: $92
| Gilead Sciences | None | $92 | 1 payment
|
2019: $129
| Gilead Sciences | None | $129 | 6 payments
|
Professional record
- NPI
- 1740499193
- Licence
- CA C53683, MA 152384California C53683: Current · expires 2026-11-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-05-22
- NPI last updated
- 2012-01-13
This is when the NPI record was last certified, not a medical board exam.